financetom
Business
financetom
/
Business
/
Commerce Bancshares to buy Florida peer FineMark in $585 million deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Commerce Bancshares to buy Florida peer FineMark in $585 million deal
Jun 16, 2025 6:26 AM

(Reuters) -U.S. regional bank Commerce Bancshares has agreed to acquire rival FineMark Holdings in an all-stock deal valued at $585 million, the companies said on Monday.

Consolidation among U.S. banks is expected to heighten as rising technology and compliance costs push lenders to scale via mergers and acquisitions. A lighter regulatory touch under the Trump administration is also fueling prospects of bigger deals.

Shareholders will receive 0.69 shares of Commerce for each share of FineMark they hold. As of the market close on Friday, the terms represent a 54.7% premium for FineMark shareholders, according to Reuters calculations.

Founded in 2007, Florida-based FineMark offers wide-ranging banking and non-banking services to clients through 13 offices in Florida, Arizona and South Carolina. The bank had $4 billion in assets, as of March 31.

The company's trust and investment business holds assets under administration of around $7.7 billion.

"Together, with over $36 billion in assets and over $82 billion in wealth assets under administration, we are poised to accelerate growth, expand our reach, and deliver even greater value,," said John Kemper, CEO of Kansas City, Missouri-based Commerce Bancshares.

Keefe, Bruyette & Woods acted as financial adviser to Commerce Bancshares, while Piper Sandler advised FineMark.

The transaction is expected to close on January 1.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Top Premarket Decliners
Top Premarket Decliners
Sep 17, 2024
07:48 AM EDT, 09/17/2024 (MT Newswires) -- Netcapital ( NCPL ) shares slumped 28% pre-bell Tuesday after the company reported a wider fiscal Q1 loss on lower revenue. Bone Biologics ( BBLG ) shares fell 15%, paring Monday's 136% rally. Dermata Therapeutics ( DRMA ) shares were down 9% after the company priced a $3.5 million private placement of common...
BridgeBio Pharma Says Infigratinib Receives US FDA Breakthrough Therapy Designation
BridgeBio Pharma Says Infigratinib Receives US FDA Breakthrough Therapy Designation
Sep 17, 2024
07:57 AM EDT, 09/17/2024 (MT Newswires) -- BridgeBio Pharma ( BBIO ) said Tuesday that the US Food and Drug Administration has granted Breakthrough Therapy Designation to oral infigratinib, which the biopharmaceutical company is developing to treat children with achondroplasia. Shares of BridgeBio Pharma ( BBIO ) were up 1.8% in recent Tuesday premarket activity. Price: 26.75, Change: +0.56, Percent...
Vigil Neuroscience Says FDA Lifts Partial Hold on Phase 1 Trial of Potential Alzheimer's Drug
Vigil Neuroscience Says FDA Lifts Partial Hold on Phase 1 Trial of Potential Alzheimer's Drug
Sep 17, 2024
07:49 AM EDT, 09/17/2024 (MT Newswires) -- Vigil Neuroscience ( VIGL ) said Tuesday that the US Food and Drug Administration has removed the partial hold on its phase 1 clinical trial of VG-3927, a potential therapy for Alzheimer's disease, based on a complete response it submitted to the agency. The company said it has started dosing a group of...
Flow Beverage Q3 Adjusted Loss Narrows as Net Revenue Rises
Flow Beverage Q3 Adjusted Loss Narrows as Net Revenue Rises
Sep 17, 2024
07:54 AM EDT, 09/17/2024 (MT Newswires) -- Flow Beverage ( FLWBF ) on Tuesday said its third-quarter adjusted loss narrowed while net revenue rose slightly. The water company said its adjusted net loss fell to $5.6 million from $12.25 million in the year-ago quarter. Consolidated net revenue rose 5% to $13.8 million. Brand net revenue contracted 15% to $8.4 million,...
Copyright 2023-2025 - www.financetom.com All Rights Reserved